These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34316657)

  • 1. Operation of the percutaneous endoscopic gastrostomy-jejunostomy tube without endoscopy in patients with Parkinson's disease on levodopa-carbidopa intestinal gel infusion therapy.
    Mukai Y; Toyoda H; Miyama K; Takahashi Y
    Clin Park Relat Disord; 2020; 3():100079. PubMed ID: 34316657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technique and outcome of percutaneous endoscopic transgastric jejunostomy for continuous infusion of levodopa-carbidopa intestinal gel for treatment of Parkinson's disease.
    Ishibashi Y; Shimo Y; Yube Y; Oka S; Egawa H; Kohira Y; Kaji S; Kanda S; Oyama G; Hatano T; Hattori N; Fukunaga T
    Scand J Gastroenterol; 2019 Jun; 54(6):787-792. PubMed ID: 31125265
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study.
    Zulli C; Sica M; De Micco R; Del Prete A; Amato MR; Tessitore A; Ferraro F; Esposito P
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2413-7. PubMed ID: 27338069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed Diagnosis of Buried Bumper Syndrome When Only the Jejunostomy Extension is Used in a Percutaneous Endoscopic Gastrostomy-jejunostomy Levodopa-carbidopa Intestinal Gel Delivery System.
    Abu-Heija AA; Tama M; Abu-Heija U; Khalid M; Al-Subee O
    Cureus; 2019 Apr; 11(4):e4568. PubMed ID: 31281751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practice in placement of percutaneous endoscopic gastrostomy with jejunal extension tube for continuous infusion of levodopa carbidopa intestinal gel in the treatment of selected patients with Parkinson's disease in the Nordic region.
    Dam-Larsen S; Darkahi B; Glad A; Gleditsch D; Gustavsson L; Halttunen J; Johansson KE; Pischel A; Reiertsen O; Törnqvist B; Zebski H
    Scand J Gastroenterol; 2015; 50(12):1500-7. PubMed ID: 26083798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study.
    Blaise AS; Baille G; Carrière N; Devos D; Dujardin K; Grolez G; Kreisler A; Kyheng M; Moreau C; Mutez E; Seguy D; Defebvre L
    Rev Neurol (Paris); 2020 May; 176(4):268-276. PubMed ID: 31668287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of enteral access for continuous delivery of levodopa-carbidopa in patients with advanced Parkinson's disease.
    Cheron J; Deviere J; Supiot F; Ballarin A; Eisendrath P; Toussaint E; Huberty V; Musala C; Blero D; Lemmers A; Van Gossum A; Arvanitakis M
    United European Gastroenterol J; 2017 Feb; 5(1):60-68. PubMed ID: 28405323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Per-oral image guided gastrojejunostomy insertion for levodopa-carbidopa intestinal gel in Parkinson's disease is safe and may be advantageous.
    Baig F; Boca M; Mooney L; Cheminais L; Selikhova M; Rolinski M; Szewczyk-Krolikowski K; Collin N; Whone A
    Parkinsonism Relat Disord; 2021 Aug; 89():34-37. PubMed ID: 34218045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of tube replacement timing during LCIG therapy on PEG-J associated adverse events: a retrospective multicenter observational study.
    Yamashita K; Yube Y; Yamazaki Y; Fukuchi T; Kato M; Koike T; Uehara T; Ikeda Y; Furune S; Murakami H; Kubota E; Fujioka S; Sato Y; Jin X; Suzuki T; Furukawa K; Tsuboi Y
    BMC Neurol; 2021 Jun; 21(1):242. PubMed ID: 34172002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
    Udd M; Lyytinen J; Eerola-Rautio J; Kenttämies A; Lindström O; Kylänpää L; Pekkonen E
    Brain Behav; 2017 Jul; 7(7):e00737. PubMed ID: 28729942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials.
    Lew MF; Slevin JT; Krüger R; Martínez Castrillo JC; Chatamra K; Dubow JS; Robieson WZ; Benesh JA; Fung VS
    Parkinsonism Relat Disord; 2015 Jul; 21(7):742-8. PubMed ID: 25962554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of PEG-J associated complications in 14 adult patients treated with levodopa-carbidopa intestinal gel].
    Shimamura M; Shinzaki S; Ikenaka K; Konaka K; Hirozawa D; Ishikura T; Hideshima M; Nakano T; Kitano T; Takehara T; Mochizuki H
    Rinsho Shinkeigaku; 2019 Mar; 59(3):153-156. PubMed ID: 30814443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buried bumper syndrome in percutaneous endoscopic gastrostomy with a jejunal extension tube in patients undergoing levodopa-carbidopa intestinal gel treatment.
    Nakagawa M; Inoue N; Takise S; Takayanagi M; Kubo T; Muroi H; Nakajima M; Morita S; Nakamura T; Kojima K
    Surg Case Rep; 2023 Dec; 9(1):213. PubMed ID: 38072871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Endoscopic Transgastric Jejunostomy (PEG-J) Tube Placement for Levodopa-Carbidopa Intrajejunal Gel Therapy in the Interventional Radiology Suite: A Long-term Follow-up.
    Saddi MV; Sarchioto M; Serra G; Murgia D; Ricchi V; Melis M; Arca R; Carreras P; Sitzia L; Zedda S; Dui G; Rossi R; Ticca A; Melis M; Cossu G
    Mov Disord Clin Pract; 2018; 5(2):191-194. PubMed ID: 30363413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications and troubleshooting at the initial introduction of Levodopa-carbidopa continuous infusion gel therapy: A single-center study].
    Mukai Y; Nishikawa N; Takahashi Y; Murata M
    Rinsho Shinkeigaku; 2019 Apr; 59(4):177-184. PubMed ID: 30930364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal burying of the jejunal-tube of a PEG-J levodopa-carbidopa release system for Parkinson's disease. Successful endoscopic management.
    Moralejo Lozano Ó; Barrajón Masa AJ; Colmenares Bulgheroni M
    Rev Esp Enferm Dig; 2021 Mar; 113(3):226-227. PubMed ID: 33207895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of an atropine/midazolam and target controlled infusion propofol-based moderate sedation protocol during percutaneous endoscopic transgastric jejunostomy procedures in Parkinson's disease: a real-life retrospective observational study.
    Gravina AG; Pellegrino R; De Micco R; Dellavalle M; Grasso A; Palladino G; Satolli S; Ciaravola M; Federico A; Tessitore A; Romano M; Ferraro F
    Front Med (Lausanne); 2023; 10():1233575. PubMed ID: 37771983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson’s disease patients.
    Sücüllü Karadağ Y; Saltoğlu T; Erdoğan Küçükdağli F; Öztürk Ö; Köseoğlu HT; Altiparmak E
    Turk J Med Sci; 2021 Feb; 51(1):84-89. PubMed ID: 32718129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An easier method for percutaneous endoscopic gastrojejunostomy tube placement.
    Sibille A; Glorieux D; Fauville JP; Warzée P
    Gastrointest Endosc; 1998 Nov; 48(5):514-7. PubMed ID: 9831842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct endoscopic placement of percutaneous endoscopic gastrostomies with jejunal extension tubes (PEG-J) using ultra-thin endoscopes - long-term outcomes from a U.S. tertiary referral center.
    Hasan Y; Ali A; Sayed AE; Levin A; Gerke H; Jhun HY; Mokadem M; Abiad RE; Jesudoss R; Polyak S; Sahar N
    Surg Endosc; 2022 Jun; 36(6):4233-4238. PubMed ID: 34642797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.